Ameriprise
CRBU icon

Ameriprise’s Caribou Biosciences CRBU Stock Holding History

Ameriprise’s Portfolio CRBU Stock Details CRBU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$55.9K Sell
29,430
-55,674
-65% -$95.6K ﹤0.01% 3998
2025
Q4 		$135K Sell
85,104
-250
-0.3% -$525 ﹤0.01% 3973
2025
Q3 		$199K Sell
85,354
-223,601
-72% -$422K ﹤0.01% 3902
2025
Q2 		$389K Sell
308,955
-99,103
-24% -$97.5K ﹤0.01% 3611
2025
Q1 		$373K Hold
408,058
– – ﹤0.01% 3605
2024
Q4 		$649K Buy
+408,058
New +$821K ﹤0.01% 3424
2024
Q2 		– Sell
-36,555
Closed -$188K – 3876
2024
Q1 		$188K Buy
36,555
+4
+0% +$25 ﹤0.01% 3700
2023
Q4 		$209K Sell
36,551
-5,825
-14% -$28.8K ﹤0.01% 3714
2023
Q3 		$203K Sell
42,376
-58,495
-58% -$363K ﹤0.01% 3700
2023
Q2 		$429K Buy
100,871
+63,119
+167% +$284K ﹤0.01% 3494
2023
Q1 		$200K Buy
37,752
+875
+2% +$5.45K ﹤0.01% 3730
2022
Q4 		$237K Sell
36,877
-1,315
-3% -$11.7K ﹤0.01% 3665
2022
Q3 		$403K Buy
+38,192
New +$356K ﹤0.01% 3472

Other funds holding CRBU

P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Ameriprise's CRBU Position: Q1 2026 in Review

Ameriprise reduced its Caribou Biosciences (CRBU) stake by 65% in Q1 2026, selling an estimated $95.6K and leaving 29,430 shares worth $55.9K. The position accounts for ﹤0.01% of the portfolio, ranked #3998.

Ameriprise first reported a position in CRBU in Q3 2022 and has held it in 13 quarters since. The position peaked at $649K in Q4 2024. 137 funds tracked by Wall St. Rank hold CRBU as of Q1 2026.

  • Ameriprise held 29,430 shares of Caribou Biosciences worth $55.9K as of Q1 2026.
  • Ameriprise sold 55,674 Caribou Biosciences shares in Q1 2026, an estimated $95.6K.
  • Caribou Biosciences made up ﹤0.01% of Ameriprise's portfolio in Q1 2026, its #3998 holding.
  • Ameriprise first reported a position in Caribou Biosciences in Q3 2022 and has held it in 13 quarters since.
  • Ameriprise's Caribou Biosciences position peaked at $649K in Q4 2024.
  • 137 funds tracked by Wall St. Rank held Caribou Biosciences as of Q1 2026.

Based on Ameriprise's 13F filing for Q1 2026, filed 15 May 2026.